|
RAD18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.042800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.709220E-01 |
| Normal-vs-Stage2 |
2.897800E-01 |
| Normal-vs-Stage3 |
4.166200E-01 |
| Normal-vs-Stage4 |
5.129600E-01 |
| Stage1-vs-Stage2 |
3.823700E-02 |
| Stage1-vs-Stage3 |
6.707800E-01 |
| Stage1-vs-Stage4 |
6.052600E-01 |
| Stage2-vs-Stage3 |
8.319500E-02 |
| Stage2-vs-Stage4 |
1.273030E-01 |
| Stage3-vs-Stage4 |
9.253600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.560040E-01 |
| Normal-vs-AfricanAmerican |
1.262380E-01 |
| Normal-vs-Asian |
3.903000E-01 |
| Caucasian-vs-AfricanAmerican |
3.523600E-01 |
| Caucasian-vs-Asian |
9.550600E-01 |
| AfricanAmerican-vs-Asian |
4.193800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.140800E-01 |
| Normal-vs-Female |
1.641370E-01 |
| Male-vs-Female |
1.102240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.671700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.246000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.226200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.944800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.483800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.435600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.414000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.671200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.196400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.474000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.954200E-01 |
| Classical-VS-Follicular |
1.69080305312264E-11 |
| Classical-VS-Other |
7.824400E-02 |
| Classical-VS-Normal |
8.320000E-03 |
| Tall-VS-Follicular |
2.66920000002724E-06 |
| Tall-VS-Other |
3.381800E-02 |
| Tall-VS-Normal |
2.467700E-02 |
| Follicular-VS-Other |
6.322400E-01 |
| Follicular-VS-Normal |
7.204300E-04 |
| Other-VS-Normal |
2.731600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.701600E-01 |
| Normal-vs-N1 |
9.340200E-01 |
| N0-vs-N1 |
6.024600E-01 |
|
|
